Melissa Levine, Peggy Bodin, Esra Krause

Research data and samples can hold tremendous value to companies and researchers, requiring time, effort, money, and often consent to collect, store, and test. But once a study is complete, does that mean everything must be discarded or can’t be further used?  Often there are questions, during and after studies, about whether the data and samples can be used for additional analyses, other testing, and future research. This panel will discuss what types of laws and agreements govern the secondary use of data and samples, and possible pathways for secondary uses. The panel also will discuss some of the practical realities of managing secondary uses internally and how to mitigate the typical challenges and legal risks.

Melissa Levine, Counsel, Global Regulatory, Hogan Lovells
Peggy Bodin, Global Privacy Officer, ThermoFisher Scientific
Esra Krause, Executive Counsel, Privacy & Data Security, Iovance Biotherapeutics

Reading Materials:

Esra Krause

Executive Counsel, Privacy & Data Security
Iovance Biotherapeutics

Melissa Levine

Counsel, Global Regulatory
Hogan Lovells

Peggy Bodin

Global Privacy Officer
ThermoFisher Scientific